Graypoint LLC Dexcom Inc Transaction History

Graypoint LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$110.31 - $140.45 $441 - $561	4 Added 0.13%	3,047 $345,000
Q1 2024 May 02, 2024	BUY	$114.22 - $140.1 $571 - $700	5 Added 0.16%	3,043 $422,000
Q4 2023 Jan 29, 2024	BUY	$75.49 - $124.16 $229,338 - $377,198	3,038 New	3,038 $376,000
Q2 2023 Jul 21, 2023	BUY	$112.47 - $130.98 $63,095 - $73,479	561 Added 29.04%	2,493 $320,000
Q1 2023 May 02, 2023	BUY	$104.0 - $122.92 $11,440 - $13,521	110 Added 6.04%	1,932 $224,000
Q4 2022 Jan 31, 2023	BUY	$84.98 - $122.67 $154,833 - $223,504	1,822 New	1,822 $206,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

Stay updated on Graypoint LLC with notifications on news.